Next Article in Journal
Evaluation of Different Reverse Osmosis Membranes for Textile Dyeing and Finishing Wastewater Reuse
Next Article in Special Issue
Minimizing Area-Specific Resistance of Electrochemical Hydrogen Compressor under Various Operating Conditions Using Unsteady 3D Single-Channel Model
Previous Article in Journal
Extraction of Copper from Sulfuric Acid Solutions Based on Pseudo-Liquid Membrane Technology
Previous Article in Special Issue
Clean Energy Based Multigeneration System for Sustainable Cities: Thermodynamic, and Stability Analyses
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Kinetic Effects of Ciprofloxacin, Carbamazepine, and Bisphenol on Biomass in Membrane Bioreactor System at Low Temperatures to Treat Urban Wastewater

by
Laura Antiñolo Bermúdez
1,†,
Antonio Martín-Luis
1,†,
Juan Carlos Leyva Díaz
1,
María del Mar Muñío Martínez
2 and
José Manuel Poyatos Capilla
1,*
1
Department of Civil Engineering, Institute of Water Research, University of Granada, 18071 Granada, Spain
2
Department of Chemical Engineering, Institute of Water Research, University of Granada, 18071 Granada, Spain
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Membranes 2023, 13(4), 419; https://doi.org/10.3390/membranes13040419
Submission received: 3 February 2023 / Revised: 7 March 2023 / Accepted: 6 April 2023 / Published: 7 April 2023

Abstract

:
This study analysed the kinetic results in the presence and absence of micropollutants (bisphenol A, carbamazepine, ciprofloxacin, and the mixture of the three compounds) obtained with respirometric tests with mixed liquor and heterotrophic biomass in a membrane bioreactor (MBR) working for two different hydraulic retention times (12–18 h) and under low-temperature conditions (5–8 °C). Independently of the temperature, the organic substrate was biodegraded faster over a longer hydraulic retention time (HRT) with similar doping, which was probably due to the longer contact time between the substrate and microorganisms within the bioreactor. However, low values of temperature negatively affected the net heterotrophic biomass growth rate, with reductions from 35.03 to 43.66% in phase 1 (12 h HRT) and from 37.18 to 42.77% in phase 2 (18 h HRT). The combined effect of the pharmaceuticals did not worsen the biomass yield compared with the effects caused individually.

1. Introduction

Today, society has a strong environmental conscience, and attempts are being made to minimise the impact of human activities on the environment [1]. For a resource as important to the population and human activities as water, the correct management and treatment of wastewater is fundamental. Inadequate treatment can release contaminants into the natural environment. Over the last few decades, there has been a rise in the number of emerging contaminants detected in water around the world [2]. These pollutants are pharmaceutically active compounds and endocrine-disrupting chemicals [3]. Pharmaceuticals may induce a variety of physiological changes, which can be reversible or not, in non-target aquatic organisms [4]. They can reach the aquatic environment via a high number of routes, such as discharge of both raw and wastewater treated by municipal [5], hospital [6], and industrial wastewater treatment plants (WWTPs); sewer leakage [7]; landfill leachate [8]; or treated wastewater used for irrigating [9]. These compounds can be found in both raw influents and treated effluents of WWTPs, so they are of particular interest [10]. However, existing treatment plants are not designed to remove such contaminants, leading to discharge into aquatic environments [11].
Within this group of contaminants are carbamazepine, bisphenol, and ciprofloxacin. These pharmaceuticals have been chosen for the study because of their widespread use worldwide, their detection in wastewater plants, and their presence on the European Union list of substances for monitoring purposes at the European level.
Bisphenol A (2,2-(4,4-dihydroxydiphenyl) propane) is an endocrine-disrupting compound (EDC), which can alter the functioning of the endocrine system, with adverse effects on both humans and the environment. Among all EDCs, bisphenol A has more detrimental effects than others [12]. It can cause sexual dysfunctions; act as a carcinogenic agent; affect neuroendocrine functions; and increase the risk of certain diseases, such as diabetes [13,14].
Carbamazepine is an anti-epileptic drug. Its consumption is about 1000 tons per year in the world [15] and can be found in a large number of water systems [16]. Among its side effects, it has been shown that exposure to carbamazepine has negative effects on both the central nervous and digestive systems, as well as on the development of embryonic and blood cells [17].
Ciprofloxacin is an effective antibiotic when it comes to treating some kinds of diseases caused by bacillus bacteria, some kinds of Gram-positive bacteria, and entero-bacteriaceae. It has been detected in higher concentrations than other antibiotics due to its high stability against degradation because of the presence of a fluorine ion in its structure [18]. Its spread in the environment can cause antibiotic resistance, resulting in a potential long-term threat to humans [19].
Membrane bioreactor (MBR) systems have become an advancement over conventional activated sludge systems for wastewater treatment by making higher-quality effluents possible, being able to work at a high MLSS concentration, and allowing a reduction in space requirements to be achieved [20,21]. This technology also has a higher removal rate of emerging pollutants [22,23], and its capital cost is the most relevant disadvantage, which could be reduced with standardisation [24].
It is important to research not only the removal rate of those compounds but also the effect that they can exert on organic matter removal by heterotrophic biomass. To the best of our knowledge, there are no studies in the literature that report on the influence of any of these three compounds on the heterotrophic biomass performance of an MBR system at low temperatures. Other studies have analysed the kinetics and biodegradability of bisphenol A (BPA) in biological systems [25], oxidation processes [26], its removal in a nitrifying system with immobilized biomass [27], and biomass performance at higher temperatures [28]. Regarding carbamazepine, there are studies that report its removal in an MBR system [29] and other systems [30,31]. Lastly, regarding ciprofloxacin, there are studies that report its removal with different types of WWTPs [32,33] and thermal procedures [34], but none of those studies are focused on the kinetic effects at low temperatures.
Among all the variables that affect wastewater treatment, temperature has turned out to be the one with the major influence [35,36], and many WWTPs are exposed to high seasonal temperature variations.
The aims of this study were to study the effects of emerging pollutants (Bisphenol A, carbamazepine, and ciprofloxacin) on biomass stability for the correct operation of the membrane bioreactor system at low temperatures, to study the capacity of the membrane bioreactor to degrade organic matter at low temperatures, and to carry out a kinetic study in the absence and presence of emerging pollutants on samples from the above bioreactor.

2. Materials and Methods

2.1. Pilot Plant

Samples were taken from a pilot plant located in the Los Vados WWTP in Granada, Spain. It consists of two main parts: an aerated cylindrical bioreactor that functions as a mixing tank for the recirculation flow and the influent, and an 84 L tank with four submerged hollow-fibre ultrafiltration membrane modules attached (ZW-10; ZENON®), whose pore size is 0.04 µm and whose area is 0.93 m2 per membrane. Municipal wastewater from the primary settling tank of the Los Vados WWTP is the influent of the bioreactor. The entire system is schematically represented in Figure 1.
The plant operates with combined cycles of filtration and backwashing with periods of 9.67 min and 0.33 min, respectively. Filtration is carried out from the outside to the inside by means of sucking. A recirculation pump from the membrane tank to the mixing tank allows a uniform MLSS concentration to be maintained. The membrane bioreactor is supplied with a constant air flux, and waste sludge is purged from the system.
The study was carried out during the months of December and January. Under the plant operating conditions of 12 HRT (flow rate of 7.02 L/h) and 18 HRT (flow rate of 4.67 L/h) and at low operating temperatures due to the climatic conditions of the region, no increase in the fouling of the membrane modules and transmembrane pressure was observed. A cleaning and recovery cycle of the membrane modules was not necessary. The membranes worked at low fluxes and low permeability. Table 1 shows the working permeability values, which were maintained at 1.29–2.22 L/(m2 h bar).
For the characterization of the pilot plant, influent and effluent samples were analysed (temperature, pH, conductivity, MLSSs, MLVSSs, BOD5, and COD). The results obtained are reported in Table 2.
In the effluent, values of suspended solids surpassing 5 mg/L were detected in some cases, which may have been due to the membrane backwash from the effluent tank during the different experimental phases.

2.2. Reagents

BPA was obtained from Sigma-Aldrich Co. (St. Louis, MO, USA). A solution of BPA (97%; CAS No. 80-05-7; MW: 228.29 g/mol) was prepared by dissolving 2 mg of the compound [28] in 2 mL of HPLC-grade methanol (Merck, Darmstadt, Germany) [25,37] and added to the respirometer during the homogenization phase of the doping assay. Moreover, 2 mL of methanol was added to the respirometer during the control homogenization assay to avoid side effects generated by methanol addition in the doping test.
A total of 1 mg of carbamazepine was added during the doping phase to reach a concentration of 1000 µg/L in the respirometer, and 0.1 mg of ciprofloxacin was added in the same way to maintain a concentration of 100 µg/L [38].
Sodium acetate was obtained from AppliChem GmbH (Darmstadt, Germany). A stock solution of sodium acetate (99%; CAS No. 127-09-3; MW: 82.03 g/mol) of 500 mg/L was prepared; then, three different dilutions of 35, 70, and 100% [39] were used in the assays.
Mixture assays were carried out by adding the three above compounds at concentrations identical to those in the single-doping test.

2.3. Respirometric Assays

Eight different pairs of control and doping respirometric experiments were carried out. Each test of the pair had a homogenization phase, consisting in reaching an oxygen saturation state in the sample; an exogenous phase, in which the dynamic oxygen uptake rate was measured under stirring, recirculation, and aeration conditions; and an endogenous respirometric assay, which was performed to evaluate the decay coefficient by leaving the mixed liquor without aeration so that the dissolved oxygen concentration decreased to zero. They were carried out in two different phases, varying the HRT from 12 to 18 h, as reported in Table 3.
It can be seen that under the operating conditions, the F/M ratios corresponded to low organic loads with respect to the concentration of microorganisms to compensate for the low-temperature effect.
Respirometric tests were carried out using a flowing gas/static liquid-type batch respirometer called BM-Advance. The respirometer worked at 20.0 ± 0.1 °C temperature, 7.25 ± 0.50 pH, 0.906 ± 0.001 L/min air flow rate, and 2000 rpm stirring rate, and recirculation was set up to assure homogenization in the respirometer. Mixed liquor samples of one litre were transferred from the pilot plant to the respirometer for each of the assay pairs.
Firstly, each sample was homogenized and aerated for 24 h before the assay started [39]. Then, the first exogenous control respirometric assay was carried out by adding the three known sodium acetate dilutions S1, S2, and S3, as shown in Figure 2.
Afterwards, an endogenous respiration assay without air flow was carried out, resulting in a graph similar to that in Figure 3.
The Rs rate is the rate of consumption in exogenous assays in the presence of a substrate and a constant supply of O2, while the OUR rate is the rate of consumption in the absence of a substrate and without O2 supply.
Finally, 2 identical assays were carried out after doping the pertinent compounds into the same sludge sample.

2.4. Kinetic Modelling

In order to model the kinetics of the analysed biomass, the yield coefficient of heterotrophic biomass referred to oxygen (YH), the maximum specific growth rate of heterotrophic biomass (µmax), the half-saturation coefficient of organic matter (KM), and the decay coefficient of heterotrophic biomass (bH) were calculated following the kinetic parameter estimation of heterotrophic biomass [28]. This estimation consisted of eight different steps.
Step 1: By integrating the Rs from Equation (1), oxygen consumption (OC) was determined for each of the three additions of sodium acetate dilutions (S1, S2, and S3).
OC = t 0 t R s dt   ( mgO 2 / L )
Step 2: YH was calculated with Equation (2).
Y H = S - OC S · f cv   ( mgVSS / mgCOD )
where fcv is a conversion factor of 1.48 mgCOD/mgVSS.
Step 3: µemp can be obtained from the relation between the biomass growth rate and the substrate degradation rate, as Equation (3) shows.
µ emp = Y H · R s 1 Y H · f cv · X H   ( h 1 )
Step 4: By linearizing the Monod model, KM and µm,H were assessed according to Equation (4).
1 µ emp = 1 µ m , H + K M µ m , H · 1 S h
Step 5: The estimation of bH was performed according to Equation (5).
b H = OUR end 1 . 42 · X T · 1 Y H 1 f p   day 1
where (1 − fp) is the fraction of volatile biomass (mgVSS/mgTSS) and OURend is the endogenous oxygen uptake rate.
Step 6: The assessment of kinetic parameters at working temperature was performed by applying the Metcalf equation [40], as shown in Equation (6).
r T = r 20 · θ ( T 20 )
where rT and r20 are the kinetic parameters at working temperature and at 20 °C, respectively; θ is a fitting standard parameter with a value of 1.04 for the MBR; and T is the working temperature.
Step 7: The evaluation of the substrate degradation rate of organic matter removal, rsu,H, was performed according to Equation (7).
r su , H = μ m , H · S · X H Y H · K M + S mgO 2 L · h
Step 8: The estimation of net heterotrophic biomass growth rate, r’x,H, based on the biomass growth rate and the decay rate, was performed as shown in Equation (8).
r x , H = μ m , H · S K M + S   · X H b H · X H   ( mgO 2 / ( L · h ) )

3. Results and Discussion

3.1. Dynamic and Static Oxygen Uptake Rates

The exogenous respiration test results of operation phases 1 (12 h HRT) and 2 (18 h HRT) are included in Figure 4 and Figure 5, respectively.
In operation phase 1, the presence of BPA or ciprofloxacin did not modify the duration of the respirometric assays. On the other hand, the shock of carbamazepine increased the duration of the respirometric tests from 3000 to 3500 s. The mix of emerging pollutants showed the same effect as carbamazepine, extending the duration from 2600 to 3000 s approximately, which implies that there was more time for the heterotrophic biomass to degrade the organic matter substrate. This suggests a higher influence of carbamazepine on the duration of the kinetic experiments.
In relation to operation phase 2, both carbamazepine and ciprofloxacin caused an increase in the duration of the respirometric tests, around 500 s each. However, BPA did not change the duration of these experiments. The same trend was observed with the mix of emerging compounds, which suggests a higher effect of BPA over longer HRTs.
Regarding the values of Rs, the pharmaceuticals reduced the three maximum values of Rs of the respirometric tests, with the exception of ciprofloxacin, in phase 1. This effect was not observed in phase 2, which could have been due to the fact that operation over a longer HRT compensated the possible reduction in Rs. In light of this, the addition of ciprofloxacin even favoured the dynamic oxygen uptake rate.
In comparing the Rs values of both operation phases, it should be highlighted that phase 1 assays in the presence of pollutants had lower Rs values than phase 2 essays, which could have been due to the better operation conditions corresponding to second-phase samples, i.e., a longer HRT and slightly higher MLSS concentrations (Figure 4 and Figure 5).
The endogenous respiration tests of the eight pairs of experiments are included in Figure 6 and Figure 7.
In general, the presence of pollutants in both phases tended to decrease the maximum value of the OUR, i.e., the endogenous oxygen uptake rate (OURend), compared with the values corresponding to the control tests. Additionally, as previously observed for Rs, the OURend values in the presence of the emerging pollutants were higher in phase 2 than in phase 1, which might have been caused by the most favourable operation conditions of phase 2 (a longer HRT and higher MLSS concentrations).
The different trends of Rs and OUR were considered in order to evaluate the kinetic parameters following the mathematical procedure described in Equations (1)–(8).

3.2. Heterotrophic Kinetic Modelling

The kinetic parameters of heterotrophic biomass in the absence and presence of pollutants calculated following the kinetic modelling steps described in the Kinetic Modelling section are indicated in Table 4 and Table 5 at respirometry temperature (20 °C) and at operation temperature, respectively.
In addition, Figure 8 shows the variables rsu,H and r’x,H, which encompass the rest of the kinetic parameters, in the absence and presence of the emerging pollutants at 20 °C.
In addition, Figure 9 shows the variables rsu,H and r’x,H, which encompass the rest of the parameters, in the absence and presence of the emerging pollutants at operation temperature.
In phase 1, independently of the temperature, the maximum specific growth rate of heterotrophic biomass decreased by 62.26% and 49.82% in the presence of BPA and ciprofloxacin, respectively. However, this kinetic parameter increased by 21.32% when carbamazepine was added. In the presence of the mix of emerging pollutants, μm was higher (37.37%), which suggested a higher effect of carbamazepine. In phase 2, all contaminants reduced the μm values by 28.86% to 62.24%, with a reduction of 38.56% in the presence of the mix of emerging pollutants. Consequently, a longer HRT did not improve the maximum specific growth rate. Moreover, operation at low values of temperature (Table 3) decreased the values of the maximum specific growth rate by 37.54% to 44.47% in phase 1 and 42.25% to 44.47% in phase 2. The overall trend of reduction in μm implied that the heterotrophic biomass required more time to oxidize organic matter in the presence of emerging pollutants and at lower temperatures.
KM showed a similar trend in both phases. In phase 1, we observed a reduction in the half-saturation coefficient for organic matter in the presence of BPA (69.99%) and ciprofloxacin (49.25%), with increase percentages of 27.16% and 127.49% with carbamazepine and the mix of emerging compounds, respectively. In phase 2, KM was reduced in the presence of pollutants by 29.26% to 77.52% with the individual shocks and by 54.21% with the mix of pollutants. In this case, operation over a longer HRT seemed to improve the half-saturation coefficient of organic matter. The effect of the drop in temperature was identical to that obtained for the maximum specific growth rate with the same reduction percentages. The global pattern of the reduction in KM could indicate that less available substrate was required to reach μm, which indicates that the system was not inhibited by the substrate.
Regarding the amount of heterotrophic biomass produced per substrate oxidized, represented by the yield coefficient, the results do not show any clear trend, with increases ranging from 1.88% to 1.98% with BPA and from 0.56% to 1.55% with the mix of emerging pollutants in both phases. Carbamazepine exerted a negative effect on this parameter, with reduction percentages of 1.38–2.58%, whereas ciprofloxacin increased YH over the 12 h HRT (0.12%) and reduced it over the 18 h HRT (6.31%). Thus, the influence of the different emerging pollutants on this kinetic parameter was almost negligible. Nevertheless, a clear reduction in the amount of heterotrophic biomass produced per organic matter oxidized was observed at operation temperature, with reduction percentages similar to those obtained for μm and KM.
Finally, the bH values decreased in the presence of pollutants by 24.76% to 66.51% with the individual shocks and by 15.19% with the mix of contaminants in phase 1. However, the trend changed in phase 2 with ciprofloxacin and the mix of emerging pollutants, with increases of 24.53% and 17.89%, respectively, which suggests a higher effect of the HRT with these shocks. Therefore, the biomass decay rate for heterotrophic biomass was reduced in the presence of pollutants with the exception of ciprofloxacin and the mix of emerging pollutants over the 18 h HRT. These latter two cases indicate a higher quantity of biomass being oxidized per day, which leads to higher loss of cell mass in the presence of ciprofloxacin, and its mix with BPA and carbamazepine over longer HRTs. As seen with μm, the temperature also reduced the decay rate for heterotrophic bacteria, with reduction percentages similar to those observed at 20 °C.
The effect of these variations in the kinetic parameters that characterize the heterotrophic bacteria in the membrane bioreactor are included in the values of the substrate degradation rate of organic matter removal and the net heterotrophic biomass growth rate (Table 4 and Table 5). Both rsu,H and r’x,H showed trends similar to those observed for μm and KM. In particular, in phase 1, rsu,H decreased by 61.27% and 62.03% in the presence of BPA at 20 °C and 5 °C, respectively, and lessened by 46.10% and 47.54% in the presence of ciprofloxacin at 20 °C and 7 °C, respectively. For its part, carbamazepine caused increases in rsu,H of 21.87% and 22.81% at 20 °C and 8 °C, respectively. The same pattern occurred with the mix of the three emerging pollutants, with increases in rsu,H of 31.23% and 33.41% at 20 °C and 6 °C, respectively, indicating a possible higher effect of carbamazepine in the mix of contaminants. In phase 2, over a longer HRT, all contaminants reduced the degradation rate of organic matter by 21.25% to 57.43% at 20 °C and 22.44% to 59.69% at 5–6 °C, with reductions of 35.94% at 20 °C and 37.47% at 5 °C in the presence of the mix of the emerging pollutants. On the other hand, no significant differences were observed when the temperature decreased from 20 °C to the operation values, with slight rises from 0.90% to 7.58%. It must be highlighted that independently of the temperature, organic matter was degraded faster over a longer HRT with similar doping due to the longer contact time between the substrate and microorganisms within the bioreactor.
Regarding the behaviour of r’x,H, the pattern was similar to that described for rsu,H, with increases in r’x,H of 58.25% and 61.08% at 20 °C and 6 °C in the presence of the mix of pollutants in phase 1. Nevertheless, in the presence of the mix of contaminants, over the 18 h HRT, the net heterotrophic biomass growth rate lessened by 43.84% and 45.19% at 20 °C and 5 °C, respectively. This could be based on lower biomass activity during operation over the 18 h HRT. Furthermore, operation at low values of temperature (Table 3) decreased the values of the net heterotrophic biomass growth rate by 35.03% to 43.66% in phase 1 and 37.18% to 42.77% in phase 2, which indicates an evident effect of temperature on r’x,H.
Concerning the synergic effect of the three compounds, it was not observed on rsu,H and r’x,H, independently of the temperature, since the values of these kinetic rates were included in the ranges obtained with the individual shock of each emerging pollutant. In particular, at operation temperature, the values of rsu,H with the individual additions varied from 18.6876 to 52.1435 mgO2/(L·h) over the 12 h HRT and changed from 45.9095 to 52.8674 mgO2/(L·h) over the 18 h HRT, where the values obtained with the mix of contaminants were 40.1192 and 46.6750 mgO2/(L·h), respectively. Regarding the values of r’x,H, these ranged from 4.0965 to 21.1980 mgVSS/(L·h) over the 12 h HRT and varied from 10.2832 to 14.5019 mgVSS/(L·h) over the 18 h HRT, where the values obtained with the mix of pollutants were 11.9389 and 12.3083 mgVSS/(L·h), respectively. In light of this, the three-compound synergic effect did not worsen the results obtained with the individual shocks.
It is important to point out that the behaviour of the heterotrophic biomass was contrary to that observed by other authors in the presence of BPA [28]. In particular, at temperatures of 12.1–31.1 °C, the above authors obtained rsu,H values varying from 50 to 200 mgO2/(L·h) and r’x,H ranging from 20 to 170 mgVSS/(L·h) in the presence of BPA, which exceeded the values corresponding to the absence of this compound. In this study, the rsu,H values varied from 18.6876 to 45.9095 mgO2/(L·h), and r’x,H ranged from 4.0965 to 14.5019 mgVSS/(L·h), which highlights a higher effect of very low temperatures on heterotrophic bacteria [35,36]. In light of this, [38] obtained that the presence of a mix of carbamazepine, ciprofloxacin, and ibuprofen almost doubled the rsu,H of the control experiment in a membrane bioreactor, with values fluctuating from 183.97 to 192.88 mgO2/(L·h) at temperatures varying from 18.9 to 21.4 °C, and the same trend was obtained by [41] in a membrane bioreactor at 12.6 and 21.5 °C. The authors of [29] did not observe any inhibition of COD removal under exogenous respiration in the presence of carbamazepine at 20 °C and similar MLSS and HRT conditions. This strengthens the higher influence of very low temperatures on the kinetic behaviour of heterotrophic bacteria, which could hinder the acclimatization of bacterial populations to the presence of micropollutants.

4. Conclusions

Based on the kinetic results in the presence and absence of micropollutants (bisphenol A, carbamazepine, ciprofloxacin, and the mixture of the three above compounds) obtained with respirometric tests carried out on heterotrophic biomass in a membrane bioreactor working over two different hydraulic retention times (12 and 18 h), at low-temperature conditions (5–8 °C), and at low MLSS concentrations (1633–2866 mg/L), the following conclusions were drawn:
  • In general, the shocks of high-concentration bisphenol A, carbamazepine, and ciprofloxacin worsened the degradation rate of organic matter and the net heterotrophic biomass growth rate, with the exception of carbamazepine and the mix of micropollutants over the 12 h HRT, which caused the reactivation of biomass with values of 52.1435 mgO2/(L·h) and 21.1980 mgVSS/(L·h) with carbamazepine at 8 °C, and 40.1192 mgO2/(L·h) and 11.9389 mgVSS/(L·h) with the mix of emerging pollutants at 6 °C. This could have been due to higher biomass activity over a lower HRT.
  • The three-compound synergic effect did not worsen the biomass performance compared with the effect of single-compound shocks, independently of temperature, with values of 40.1192 mgO2/(L·h) with the mix in relation to the range 18.6876–52.1435 mgO2/(L·h) with the individual shocks over the 12 h HRT and at operation temperature. Over the 18 h HRT, the values of single doping ranging from 45.9095 to 52.8674 mgO2/(L·h) also encompassed the value of the mix (46.6750 mgO2/(L·h)) at operation temperature. The trend of r’x,H was similar to that observed for rsu,H.
  • Low temperatures mainly inhibited the net heterotrophic biomass growth rate, with reductions from 19.8848 to 11.9389 mgVSS/(L·h) and from 21.5082 to 12.3083 mgVSS/(L·h) in the presence of the mix of emerging pollutants over the 12 h and 18 h HRTs, respectively.
  • The hydraulic retention time was the most influential variable regarding the degradation rate of organic matter, independently of temperature, with faster biodegradation rates over 18 h compared with 12 h with similar doping. Thus, hydraulic retention time plays an important role in biomass performance even at low temperatures, allowing membrane bioreactors to work under such extreme temperature conditions under the shock of micropollutants by increasing its value.

Author Contributions

Conceptualization, J.M.P.C., M.d.M.M.M. and J.C.L.D.; methodology, J.M.P.C. and M.d.M.M.M.; validation, J.C.L.D. and M.d.M.M.M.; formal analysis, J.M.P.C., J.C.L.D., M.d.M.M.M., L.A.B. and A.M.-L.; investigation, J.M.P.C., J.C.L.D., M.d.M.M.M., L.A.B. and A.M.-L.; data curation, L.A.B. and A.M.-L.; writing—original draft preparation, L.A.B. and A.M.-L.; writing—review and editing, J.M.P.C., J.C.L.D., M.d.M.M.M., L.A.B. and A.M.-L.; visualization, L.A.B. and A.M.-L.; supervision, J.M.P.C., J.C.L.D. and M.d.M.M.M.; project administration, J.M.P.C. All authors have read and agreed to the published version of the manuscript.

Funding

This study was financed by the Spanish Ministry of Science, Innovation and University Project RTI2018-101270-B-I00.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Abbreviations

BPA, bisphenol A; DO, dissolved oxygen (ppm); Rs, dynamic oxygen uptake rate (mgO2 L−1 h−1); t, time (s); T, temperature (°C); HRT, hydraulic retention time (h); MBR, membrane bioreactor; WWTP, wastewater treatment plant; MLSSs, mixed liquor suspended solids (mg L−1); OUR, static oxygen uptake rate (mgO2 L−1 h−1); OURend, endogenous oxygen uptake rate (mgO2 L−1 h−1); YH,O2, yield coefficient of heterotrophic biomass referred to oxygen; µemp, empirical specific growth rate (h−1); µmax, maximum specific growth rate of heterotrophic biomass (h−1); KM, half-saturation coefficient of organic matter (mgO2/L); MLVSSs, mixed liquor volatile suspended solids (mg L−1); COD, chemical oxygen demand (mgO2 L−1); BOD5, five-day biochemical oxygen demand (mgO2 L−1); S, substrate concentration as COD (mgO2 L−1); Xh, concentration of heterotrophic biomass (mgVSS L−1); bH, decay coefficient of heterotrophic biomass (day−1); TSSs, total suspended solids (mg L−1); XT, total biomass concentration (mgTSS L−1); rsu,H, substrate degradation rate of organic matter removal (mgO2 L−1 h−1); r’X,H, net heterotrophic biomass growth rate (mgVSS L−1 h−1); kd, decay coefficient (day−1).

References

  1. Antiñolo Bermúdez, L.; Pascual, J.M.; del Mar Muñio Martínez, M.; Manuel, J.; Capilla, P. Effectiveness of Advanced Oxidation Processes in Wastewater Treatment: State of the Art. Water 2021, 13, 2094. [Google Scholar] [CrossRef]
  2. Tran, N.H.; Reinhard, M.; Gin, K.Y.H. Occurrence and fate of emerging contaminants in municipal wastewater treatment plants from different geographical regions-a review. Water Res. 2018, 133, 182–207. [Google Scholar] [CrossRef] [PubMed]
  3. Verlicchi, P.; Zambello, E. Pharmaceuticals and personal care products in untreated and treated sewage sludge: Occurrence and environmental risk in the case of application on soil—A critical review. Sci. Total Environ. 2015, 538, 750–767. [Google Scholar] [CrossRef] [PubMed]
  4. Palma, P.; Fialho, S.; Lima, A.; Novais, M.H.; Costa, M.J.; Montemurro, N.; Pérez, S.; de Alda, M.L. Pharmaceuticals in a Mediterranean Basin: The influence of temporal and hydrological patterns in environmental risk assessment. Sci. Total Environ. 2020, 709, 136205. [Google Scholar] [CrossRef] [PubMed]
  5. Verlicchi, P.; Al Aukidy, M.; Zambello, E. Occurrence of pharmaceutical compounds in urban wastewater: Removal, mass load and environmental risk after a secondary treatment—A review. Sci. Total Environ. 2012, 429, 123–155. [Google Scholar] [CrossRef]
  6. Verlicchi, P.; Galletti, A.; Petrovic, M.; Barceló, D. Hospital effluents as a source of emerging pollutants: An overview of micropollutants and sustainable treatment options. J. Hydrol. 2010, 389, 416–428. [Google Scholar] [CrossRef]
  7. Launay, M.A.; Dittmer, U.; Steinmetz, H. Organic micropollutants discharged by combined sewer overflows—Characterisation of pollutant sources and stormwater-related processes. Water Res. 2016, 104, 82–92. [Google Scholar] [CrossRef]
  8. Yi, X.; Tran, N.H.; Yin, T.; He, Y.; Gin, K.Y.H. Removal of selected PPCPs, EDCs, and antibiotic resistance genes in landfill leachate by a full-scale constructed wetlands system. Water Res. 2017, 121, 46–60. [Google Scholar] [CrossRef]
  9. Antiñolo Bermúdez, L.; Leyva Díaz, J.C.; Martín Pascual, J.; Muñío Martínez, M.D.M.; Poyatos Capilla, J.M. Study of the Potential for Agricultural Reuse of Urban Wastewater with Membrane Bioreactor Technology in the Circular Economy Framework. Agronomy 2022, 12, 1877. [Google Scholar] [CrossRef]
  10. Tran, N.H.; Hu, J.; Ong, S.L. Simultaneous determination of PPCPs, EDCs, and artificial sweeteners in environmental water samples using a single-step SPE coupled with HPLC–MS/MS and isotope dilution. Talanta 2013, 113, 82–92. [Google Scholar] [CrossRef]
  11. Liu, H.-Q.; Lam, J.C.W.; Li, W.-W.; Yu, H.-Q.; Lam, P.K.S. Spatial distribution and removal performance of pharmaceuticals in municipal wastewater treatment plants in China. Sci. Total Environ. 2017, 586, 1162–1169. [Google Scholar] [CrossRef]
  12. Omoike, A.; Wacker, T.; Navidonski, M. Biodegradation of bisphenol A by Heliscus lugdunensis, a naturally occurring hyphomycete in freshwater environments. Chemosphere 2013, 91, 1643–1647. [Google Scholar] [CrossRef] [PubMed]
  13. Takayanagi, S.; Tokunaga, T.; Liu, X.; Okada, H.; Matsushima, A.; Shimohigashi, Y. Endocrine disruptor bisphenol A strongly binds to human estrogen-related receptor γ (ERRγ) with high constitutive activity. Toxicol. Lett. 2006, 167, 95–105. [Google Scholar] [CrossRef] [PubMed]
  14. Furuya, M.; Adachi, K.; Kuwahara, S.; Ogawa, K.; Tsukamoto, Y. Inhibition of male chick phenotypes and spermatogenesis by Bisphenol-A. Life Sci. 2006, 78, 1767–1776. [Google Scholar] [CrossRef] [PubMed]
  15. Yu, C.; Lan, S.; Cheng, S.; Zeng, L.; Zhu, M. Ba substituted SrTiO3 induced lattice deformation for enhanced piezocatalytic removal of carbamazepine from water. J. Hazard. Mater. 2022, 424, 127440. [Google Scholar] [CrossRef]
  16. Yuan, X.; Li, S.; Hu, J.; Yu, M.; Li, Y.; Wang, Z. Experiments and numerical simulation on the degradation processes of carbamazepine and triclosan in surface water: A case study for the Shahe Stream, South China. Sci. Total Environ. 2019, 655, 1125–1138. [Google Scholar] [CrossRef]
  17. Duan, Z.; Deng, L.; Shi, Z.; Zhang, H.; Zeng, H.; Crittenden, J. In situ growth of Ag-SnO2 quantum dots on silver phosphate for photocatalytic degradation of carbamazepine: Performance, mechanism and intermediates toxicity assessment. J. Colloid Interface Sci. 2019, 534, 270–278. [Google Scholar] [CrossRef]
  18. Wu, S.; Zhao, X.; Li, Y.; Zhao, C.; Du, Q.; Sun, J.; Wang, Y.; Peng, X.; Xia, Y.; Wang, Z.; et al. Adsorption of ciprofloxacin onto biocomposite fibers of graphene oxide/calcium alginate. Chem. Eng. J. 2013, 230, 389–395. [Google Scholar] [CrossRef]
  19. Malakootian, M.; Nasiri, A.; Amiri Gharaghani, M. Photocatalytic degradation of ciprofloxacin antibiotic by TiO2 nanoparticles immobilized on a glass plate. Chem. Eng. Commun. 2019, 207, 56–72. [Google Scholar] [CrossRef]
  20. Díaz, V.; Antiñolo, L.; Poyatos Capilla, J.M.; Almécija, M.C.; Muñío, M.D.M.; Martín-Pascual, J. Nutrient Removal and Membrane Performance of an Algae Membrane Photobioreactor in Urban Wastewater Regeneration. Membranes 2022, 12, 982. [Google Scholar] [CrossRef]
  21. Santos, A.; Ma, W.; Judd, S.J. Membrane bioreactors: Two decades of research and implementation. Desalination 2011, 273, 148–154. [Google Scholar] [CrossRef]
  22. Li, C.; Cabassud, C.; Guigui, C. Evaluation of membrane bioreactor on removal of pharmaceutical micropollutants: A review. Desalin. Water Treat. 2014, 55, 845–858. [Google Scholar] [CrossRef]
  23. Ganiyu, S.O.; van Hullebusch, E.D.; Cretin, M.; Esposito, G.; Oturan, M.A. Coupling of membrane filtration and advanced oxidation processes for removal of pharmaceutical residues: A critical review. Sep Purif. Technol. 2015, 156, 891–914. [Google Scholar] [CrossRef]
  24. Lesjean, B.; Huisjes, E.H. Survey of the European MBR market: Trends and perspectives. Desalination 2008, 231, 71–81. [Google Scholar] [CrossRef]
  25. Stasinakis, A.S.; Petalas, A.V.; Mamais, D.; Thomaidis, N.S. Application of the OECD 301F respirometric test for the biodegradability assessment of various potential endocrine disrupting chemicals. Bioresour. Technol. 2008, 99, 3458–3467. [Google Scholar] [CrossRef]
  26. Rivero, M.J.; Alonso, E.; Dominguez, S.; Ribao, P.; Ibañez, R.; Ortiz, I.; Irabien, A. Kinetic analysis and biodegradability of the Fenton mineralization of bisphenol A. J. Chem. Technol. Biotechnol. 2014, 89, 1228–1234. [Google Scholar] [CrossRef]
  27. Zielińska, M.; Cydzik-Kwiatkowska, A.; Bernat, K.; Bułkowska, K.; Wojnowska-Baryła, I. Removal of bisphenol A (BPA) in a nitrifying system with immobilized biomass. Bioresour. Technol. 2014, 171, 305–313. [Google Scholar] [CrossRef]
  28. Leyva-Díaz, J.C.; Calero-Díaz, G.; López-López, C.; Martín-Pascual, J.; Torres, J.C.; Poyatos, J.M. Kinetic study of the effect of bisphenol A on the rates of organic matter removal, decay and biomass generation in a membrane bioreactor. Biochem. Eng. J. 2017, 128, 45–53. [Google Scholar] [CrossRef]
  29. Aubenneau, M.; Tahar, A.; Casellas, C.; Wisniewski, C. Membrane bioreactor for pharmaceutically active compounds removal: Effects of carbamazepine on mixed microbial communities implied in the treatment. Process. Biochem. 2010, 45, 1826–1831. [Google Scholar] [CrossRef]
  30. Zhang, Y.; Geißen, S.U. In vitro degradation of carbamazepine and diclofenac by crude lignin peroxidase. J. Hazard. Mater. 2010, 176, 1089–1092. [Google Scholar] [CrossRef]
  31. Zhang, Y.; Geißen, S.U.; Gal, C. Carbamazepine and diclofenac: Removal in wastewater treatment plants and occurrence in water bodies. Chemosphere 2008, 73, 1151–1161. [Google Scholar] [CrossRef] [PubMed]
  32. Nas, B.; Dolu, T.; Koyuncu, S. Behavior and Removal of Ciprofloxacin and Sulfamethoxazole Antibiotics in Three Different Types of Full-Scale Wastewater Treatment Plants: A Comparative Study. Water Air Soil Pollut. 2021, 232, 1–15. [Google Scholar] [CrossRef]
  33. Yi, K.; Wang, D.; Yang, Q.; Li, X.; Chen, H.; Sun, J.; An, H.; Wang, L.; Deng, Y.; Liu, J.; et al. Effect of ciprofloxacin on biological nitrogen and phosphorus removal from wastewater. Sci. Total Environ. 2017, 605, 368–375. [Google Scholar] [CrossRef] [PubMed]
  34. Pan, L.J.; Li, J.; Li, C.X.; Tang, X.D.; Yu, G.W.; Wang, Y. Study of ciprofloxacin biodegradation by a Thermus sp. isolated from pharmaceutical sludge. J. Hazard. Mater. 2018, 343, 59–67. [Google Scholar] [CrossRef] [PubMed]
  35. Pei, S.; Teng, J.; Ren, N.; You, S. Low-Temperature Removal of Refractory Organic Pollutants by Electrochemical Oxidation: Role of Interfacial Joule Heating Effect. Environ. Sci. Technol. 2020, 54, 4573–4582. [Google Scholar] [CrossRef] [PubMed]
  36. Hülsen, T.; Barry, E.M.; Lu, Y.; Puyol, D.; Batstone, D.J. Low temperature treatment of domestic wastewater by purple phototrophic bacteria: Performance, activity, and community. Water Res. 2016, 100, 537–545. [Google Scholar] [CrossRef] [Green Version]
  37. Dorival-García, N.; Zafra-Gómez, A.; Oliver-Rodríguez, B.; Navalón, A.; González-López, J.; Vílchez, J.L. Effect of the injection of pure oxygen into a membrane bioreactor on the elimination of bisphenol A. Int. J. Environ. Sci. Technol. 2014, 11, 9–20. [Google Scholar] [CrossRef] [Green Version]
  38. Calero-Díaz, G.; Monteoliva-García, A.; SLeyva-Díaz, J.C.; López-López, C.; Martín-Pascual, J.; Torres, J.C.; Poyatos, J.M. Impact of ciprofloxacin, carbamazepine and ibuprofen on a membrane bioreactor system: Kinetic study and biodegradation capacity. J. Chem. Technol. Biotechnol. 2017, 92, 2944–2951. [Google Scholar] [CrossRef]
  39. Leyva-Díaz, J.C.; Calderón, K.; Rodríguez, F.A.; González-López, J.; Hontoria, E.; Poyatos, J.M. Comparative kinetic study between moving bed biofilm reactor-membrane bioreactor and membrane bioreactor systems and their influence on organic matter and nutrients removal. Biochem. Eng. J. 2013, 77, 28–40. [Google Scholar] [CrossRef]
  40. Metcalf, L.; Eddy, H.P.; Tchobanoglous, G. Wastewater Energy: Treatment and Reuse; McGraw-Hill: New York, NY, USA, 2004; p. 1819. [Google Scholar]
  41. Monteoliva-García, A.; Leyva-Díaz, J.C.; López-López, C.; Poyatos, J.M.; del Mar Muñío, M.; Martín-Pascual, J. Heterotrophic Kinetic Study and Nitrogen Removal of a Membrane Bioreactor System Treating Real Urban Wastewater under a Pharmaceutical Compounds Shock: Effect of the Operative Variables. Water 2019, 11, 1785. [Google Scholar] [CrossRef] [Green Version]
Figure 1. Schematic diagram of the pilot plant.
Figure 1. Schematic diagram of the pilot plant.
Membranes 13 00419 g001
Figure 2. Evolution example of dynamic oxygen uptake rate (Rs) in exogenous respirometric experiment and addition times of the three different dilutions of sodium acetate substrate. S1: sodium acetate addition of 5 mL; S2: sodium acetate addition of 10 mL; S3: sodium acetate addition of 15 mL.
Figure 2. Evolution example of dynamic oxygen uptake rate (Rs) in exogenous respirometric experiment and addition times of the three different dilutions of sodium acetate substrate. S1: sodium acetate addition of 5 mL; S2: sodium acetate addition of 10 mL; S3: sodium acetate addition of 15 mL.
Membranes 13 00419 g002
Figure 3. Evolution example of static oxygen uptake rate (OUR) in endogenous respirometric assay. OURend: maximum rate of consumption in endogenous respiration assay.
Figure 3. Evolution example of static oxygen uptake rate (OUR) in endogenous respirometric assay. OURend: maximum rate of consumption in endogenous respiration assay.
Membranes 13 00419 g003
Figure 4. Evolution of dynamic oxygen uptake rate (Rs) in the respirometric experiments in the absence and presence of pollutants for the determination of the kinetic parameters. (a) Phase 1: control without BPA and with BPA. (b) Phase 1: control without carbamazepine and with carbamazepine. (c) Phase 1: control without ciprofloxacin and with ciprofloxacin. (d) Phase 1: control without pharmaceuticals and with mixture of pharmaceuticals. n/BPA: absence of bisphenol A. BPA: presence of bisphenol A. n/CBZ: absence of carbamazepine. CBZ: presence of carbamazepine. n/CPF: absence of ciprofloxacin. CPF: presence of ciprofloxacin. n/Mix: absence of mix of pharmaceuticals. Mix: presence of mix of pharmaceuticals.
Figure 4. Evolution of dynamic oxygen uptake rate (Rs) in the respirometric experiments in the absence and presence of pollutants for the determination of the kinetic parameters. (a) Phase 1: control without BPA and with BPA. (b) Phase 1: control without carbamazepine and with carbamazepine. (c) Phase 1: control without ciprofloxacin and with ciprofloxacin. (d) Phase 1: control without pharmaceuticals and with mixture of pharmaceuticals. n/BPA: absence of bisphenol A. BPA: presence of bisphenol A. n/CBZ: absence of carbamazepine. CBZ: presence of carbamazepine. n/CPF: absence of ciprofloxacin. CPF: presence of ciprofloxacin. n/Mix: absence of mix of pharmaceuticals. Mix: presence of mix of pharmaceuticals.
Membranes 13 00419 g004aMembranes 13 00419 g004b
Figure 5. Evolution of dynamic oxygen uptake rate (Rs) in the respirometric experiments in the absence and presence of pollutants for the determination of the kinetic parameters. (a) Phase 2: control without BPA and with BPA. (b) Phase 2: control without carbamazepine and with carbamazepine. (c) Phase 2: control without ciprofloxacin and with ciprofloxacin. (d) Phase 2: control without pharmaceuticals and with mixture of pharmaceuticals. n/BPA: absence of bisphenol A. BPA: presence of bisphenol A. n/CBZ: absence of carbamazepine. CBZ: presence of carbamazepine. n/CPF: absence of ciprofloxacin. CPF: presence of ciprofloxacin. n/Mix: absence of mix of pharmaceuticals. Mix: presence of mix of pharmaceuticals.
Figure 5. Evolution of dynamic oxygen uptake rate (Rs) in the respirometric experiments in the absence and presence of pollutants for the determination of the kinetic parameters. (a) Phase 2: control without BPA and with BPA. (b) Phase 2: control without carbamazepine and with carbamazepine. (c) Phase 2: control without ciprofloxacin and with ciprofloxacin. (d) Phase 2: control without pharmaceuticals and with mixture of pharmaceuticals. n/BPA: absence of bisphenol A. BPA: presence of bisphenol A. n/CBZ: absence of carbamazepine. CBZ: presence of carbamazepine. n/CPF: absence of ciprofloxacin. CPF: presence of ciprofloxacin. n/Mix: absence of mix of pharmaceuticals. Mix: presence of mix of pharmaceuticals.
Membranes 13 00419 g005aMembranes 13 00419 g005b
Figure 6. Evolution of static oxygen uptake rate (OUR) in the respirometric experiments in the absence and presence of pollutants for the determination of the kinetic parameters. (a) Phase 1: control without BPA and with BPA. (b) Phase 1: control without carbamazepine and with carbamazepine. (c) Phase 1: control without ciprofloxacin and with ciprofloxacin. (d) Phase 1: control without pharmaceuticals and with mixture of pharmaceuticals. n/BPA: absence of bisphenol A. BPA: presence of bisphenol A. n/CBZ: absence of carbamazepine. CBZ: presence of carbamazepine. n/CPF: Absence of ciprofloxacin. CPF: Presence of ciprofloxacin. n/Mix: absence of mix of pharmaceuticals. Mix: presence of mix of pharmaceuticals.
Figure 6. Evolution of static oxygen uptake rate (OUR) in the respirometric experiments in the absence and presence of pollutants for the determination of the kinetic parameters. (a) Phase 1: control without BPA and with BPA. (b) Phase 1: control without carbamazepine and with carbamazepine. (c) Phase 1: control without ciprofloxacin and with ciprofloxacin. (d) Phase 1: control without pharmaceuticals and with mixture of pharmaceuticals. n/BPA: absence of bisphenol A. BPA: presence of bisphenol A. n/CBZ: absence of carbamazepine. CBZ: presence of carbamazepine. n/CPF: Absence of ciprofloxacin. CPF: Presence of ciprofloxacin. n/Mix: absence of mix of pharmaceuticals. Mix: presence of mix of pharmaceuticals.
Membranes 13 00419 g006aMembranes 13 00419 g006b
Figure 7. Evolution of static oxygen uptake rate (OUR) in the respirometric experiments in the absence and presence of pollutants for the determination of the kinetic parameters. (a) Phase 2: control without BPA and with BPA. (b) Phase 2: control without carbamazepine and with carbamazepine. (c) Phase 2: control without ciprofloxacin and with ciprofloxacin. (d) Phase 2: control without pharmaceuticals and with mixture of pharmaceuticals. n/BPA: absence of bisphenol A. BPA: presence of bisphenol A. n/CBZ: absence of carbamazepine. CBZ: presence of carbamazepine. n/CPF: absence of ciprofloxacin. CPF: presence of ciprofloxacin. n/Mix: absence of mix of pharmaceuticals. Mix: presence of mix of pharmaceuticals.
Figure 7. Evolution of static oxygen uptake rate (OUR) in the respirometric experiments in the absence and presence of pollutants for the determination of the kinetic parameters. (a) Phase 2: control without BPA and with BPA. (b) Phase 2: control without carbamazepine and with carbamazepine. (c) Phase 2: control without ciprofloxacin and with ciprofloxacin. (d) Phase 2: control without pharmaceuticals and with mixture of pharmaceuticals. n/BPA: absence of bisphenol A. BPA: presence of bisphenol A. n/CBZ: absence of carbamazepine. CBZ: presence of carbamazepine. n/CPF: absence of ciprofloxacin. CPF: presence of ciprofloxacin. n/Mix: absence of mix of pharmaceuticals. Mix: presence of mix of pharmaceuticals.
Membranes 13 00419 g007aMembranes 13 00419 g007bMembranes 13 00419 g007c
Figure 8. Evolution of rsu,H (◦) and r’x,H (Δ) in phase 1 and phase 2 at 20 °C. n/BPA: absence of bisphenol A. BPA: presence of bisphenol A. n/CBZ: absence of carbamazepine. CBZ: presence of carbamazepine. n/CPF: absence of ciprofloxacin. CPF: presence of ciprofloxacin. n/Mix: absence of mix of pharmaceuticals. Mix: presence of mix of pharmaceuticals.
Figure 8. Evolution of rsu,H (◦) and r’x,H (Δ) in phase 1 and phase 2 at 20 °C. n/BPA: absence of bisphenol A. BPA: presence of bisphenol A. n/CBZ: absence of carbamazepine. CBZ: presence of carbamazepine. n/CPF: absence of ciprofloxacin. CPF: presence of ciprofloxacin. n/Mix: absence of mix of pharmaceuticals. Mix: presence of mix of pharmaceuticals.
Membranes 13 00419 g008
Figure 9. Evolution of rsu,H (◦) and r’x,H (Δ) in phase 1 and phase 2 at operation temperature in plant. n/BPA: absence of bisphenol A. BPA: presence of bisphenol A. n/CBZ: absence of carbamazepine. CBZ: presence of carbamazepine. n/CPF: absence of ciprofloxacin. CPF: presence of ciprofloxacin. n/Mix: absence of mix of pharmaceuticals. Mix: presence of mix of pharmaceuticals.
Figure 9. Evolution of rsu,H (◦) and r’x,H (Δ) in phase 1 and phase 2 at operation temperature in plant. n/BPA: absence of bisphenol A. BPA: presence of bisphenol A. n/CBZ: absence of carbamazepine. CBZ: presence of carbamazepine. n/CPF: absence of ciprofloxacin. CPF: presence of ciprofloxacin. n/Mix: absence of mix of pharmaceuticals. Mix: presence of mix of pharmaceuticals.
Membranes 13 00419 g009
Table 1. Permeability working values, where TMP is the transmembrane pressure.
Table 1. Permeability working values, where TMP is the transmembrane pressure.
Pressure
(bar)
∆TMP
(bar)
Permeability (m3/(m2 h bar))Permeability (L/(m2 h bar))
12 HRTDecemberSuction0.050.950.0019861.99
Backwashing0.150.850.0021902.22
DecemberSuction0.200.800.0023582.36
Backwashing0.150.850.0022192.22
18 HRTJanuarySuction0.100.900.0013951.39
Backwashing0.250.750.0016741.67
JanuarySuction0.030.970.0012871.29
Backwashing0.250.750.0016741.67
Table 2. Water characterization of phase-one and -two samples, where SSs—suspended solids; VSSs—volatile suspended solids; MLSSs—mixed liquor suspended solids; MLVSSs—mixed liquor volatile suspended solids; COD—chemical oxygen demand; and BOD5—five-day biochemical oxygen demand.
Table 2. Water characterization of phase-one and -two samples, where SSs—suspended solids; VSSs—volatile suspended solids; MLSSs—mixed liquor suspended solids; MLVSSs—mixed liquor volatile suspended solids; COD—chemical oxygen demand; and BOD5—five-day biochemical oxygen demand.
Respirometry SampleSSs
(mg/L)
VSSs
(mg/L)
pHConductivity (μS/cm)COD
(mgO2/L)
BOD5 (mgO2/L)
1Influent70627.651087448240
2Influent2847.941235465300
3Influent80597.501122388230
4Influent94757.631274N/D*310
5Influent78757.681178441280
6Influent77647.481020404310
7Influent49387.801030N/D*310
8Influent109917.661178461320
1Effluent217.749745436
2Effluent1Non detected7.348864629
3Effluent947.048864713
4Effluent1016.989184713
5Effluent13117.581149469
6Effluent1188.0610454736
7Effluent4Non detected8.2310784644
8Effluent838.1010854819
Table 3. Design of experiments.
Table 3. Design of experiments.
Respirometric AssayEmerging CompoundMLSSs (mg/L)HRT
(h)
F/M
(kg BOD5/(kg MLSS day))
T
(°C)
pHConductivity (μS/cm)
1Bisphenol A2033120.01057.07895
2Carbamazepine1633120.01587.11898
3Ciprofloxacin2333120.00877.50880
4Mixture2166120.01267.00908
5Bisphenol A2400180.00668.311055
6Carbamazepine2333180.00757.921058
7Ciprofloxacin2000180.00957.851083
8Mixture2866180.00657.98973
Table 4. Kinetic parameters obtained by Equations (1)–(8) for phase one (1) and two (2) of experiments at respirometry temperature of 20 °C (where Mix—the mixture of the three compounds; μm—the maximum specific growth rate of heterotrophic biomass; KM—the half-saturation coefficient of organic matter; YH,O2—the yield coefficient for heterotrophic biomass referred to oxygen; bH—the decay coefficient of heterotrophic biomass; rsu,H—the substrate degradation rate of organic matter removal; and r’x,H—the net heterotrophic biomass growth rate).
Table 4. Kinetic parameters obtained by Equations (1)–(8) for phase one (1) and two (2) of experiments at respirometry temperature of 20 °C (where Mix—the mixture of the three compounds; μm—the maximum specific growth rate of heterotrophic biomass; KM—the half-saturation coefficient of organic matter; YH,O2—the yield coefficient for heterotrophic biomass referred to oxygen; bH—the decay coefficient of heterotrophic biomass; rsu,H—the substrate degradation rate of organic matter removal; and r’x,H—the net heterotrophic biomass growth rate).
Emerging PollutantConditionμm (h−1) KM (mgO2/L) YH (mgVSS/mgO2) bH (day−1) rsu,H
(mgO2/(L h))
r’x,H
(mgVSS/(L h))
BPA (1)Control0.02243.68230.62430.101147.816923.8453
Doped0.00841.10490.63670.076118.52097.27150
Carbamazepine (1)Control0.02594.02240.68680.057341.177525.4455
Doped0.03145.11480.66910.019250.184732.6281
Ciprofloxacin (1)Control0.03787.81640.66160.047885.752253.2429
Doped0.01893.96710.66240.035146.222228.0582
Mixture (1)Control0.01361.56020.65970.113229.664712.5654
Doped0.01873.54920.66340.096038.929019.8848
BPA (2)Control0.04559.20840.65970.1240105.874160.3232
Doped0.01722.07040.67200.074845.074024.5512
Carbamazepine (2)Control0.02906.84680.60310.133680.973338.0842
Doped0.01724.54700.59480.117250.793420.7853
Ciprofloxacin (2)Control0.02836.38990.60830.127360.613328.9932
Doped0.02014.52000.56990.158547.731917.3922
Mixture (2)Control0.02155.48440.62810.066871.245638.3015
Doped0.01322.51140.63780.078845.643021.5082
(1): phase 1 (12 h HRT); (2): phase 2 (18 h HRT).
Table 5. Kinetic parameters obtained using Equations (1)–(8) for phase one (1) and two (2) of experiments at operation temperature existing in plant (where Mix—the mixture of the three compounds; μm—the maximum specific growth rate of heterotrophic biomass; KM—the half-saturation coefficient of organic matter; YH,O2—the yield coefficient of heterotrophic biomass referred to oxygen; bH—the decay coefficient of heterotrophic biomass; rsu,H—the substrate degradation rate of organic matter removal; and r’x,H—the net heterotrophic biomass growth rate).
Table 5. Kinetic parameters obtained using Equations (1)–(8) for phase one (1) and two (2) of experiments at operation temperature existing in plant (where Mix—the mixture of the three compounds; μm—the maximum specific growth rate of heterotrophic biomass; KM—the half-saturation coefficient of organic matter; YH,O2—the yield coefficient of heterotrophic biomass referred to oxygen; bH—the decay coefficient of heterotrophic biomass; rsu,H—the substrate degradation rate of organic matter removal; and r’x,H—the net heterotrophic biomass growth rate).
Emerging PollutantConditionμm (h−1) KM (mgO2/L) YH (mgVSS/mgO2) bH (day−1) rsu,H
(mgO2/(L h))
r’x,H
(mgVSS/(L h))
BPA (1)Control0.01242.04470.34670.056249.214113.7248
Doped0.00470.61350.35350.042318.68764.0965
Carbamazepine (1)Control0.01622.51240.42900.035842.459216.4430
Doped0.01963.19470.41790.012052.143521.1980
Ciprofloxacin (1)Control0.02274.69430.39740.028790.931234.0342
Doped0.01142.38250.39780.021147.705317.4411
Mixture (1)Control0.00790.90100.38090.065330.07307.4117
Doped0.01082.04960.38310.055440.119211.9389
BPA (2)Control0.02635.31760.38090.0716113.901237.8930
Doped0.00991.19560.38810.043245.909515.5019
Carbamazepine (2)Control0.01613.80180.33490.074285.826722.7722
Doped0.00952.52480.33030.065152.867412.2263
Ciprofloxacin (2)Control0.01573.54810.33780.070764.089717.2732
Doped0.01122.50980.31640.088049.709910.2832
Mixture (2)Control0.01193.04530.34880.037174.650022.4548
Doped0.00731.39450.35420.043746.675012.3083
(1): phase 1 (12 h HRT); (2): phase 2 (18 h HRT).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Antiñolo Bermúdez, L.; Martín-Luis, A.; Leyva Díaz, J.C.; Muñío Martínez, M.d.M.; Poyatos Capilla, J.M. Kinetic Effects of Ciprofloxacin, Carbamazepine, and Bisphenol on Biomass in Membrane Bioreactor System at Low Temperatures to Treat Urban Wastewater. Membranes 2023, 13, 419. https://doi.org/10.3390/membranes13040419

AMA Style

Antiñolo Bermúdez L, Martín-Luis A, Leyva Díaz JC, Muñío Martínez MdM, Poyatos Capilla JM. Kinetic Effects of Ciprofloxacin, Carbamazepine, and Bisphenol on Biomass in Membrane Bioreactor System at Low Temperatures to Treat Urban Wastewater. Membranes. 2023; 13(4):419. https://doi.org/10.3390/membranes13040419

Chicago/Turabian Style

Antiñolo Bermúdez, Laura, Antonio Martín-Luis, Juan Carlos Leyva Díaz, María del Mar Muñío Martínez, and José Manuel Poyatos Capilla. 2023. "Kinetic Effects of Ciprofloxacin, Carbamazepine, and Bisphenol on Biomass in Membrane Bioreactor System at Low Temperatures to Treat Urban Wastewater" Membranes 13, no. 4: 419. https://doi.org/10.3390/membranes13040419

APA Style

Antiñolo Bermúdez, L., Martín-Luis, A., Leyva Díaz, J. C., Muñío Martínez, M. d. M., & Poyatos Capilla, J. M. (2023). Kinetic Effects of Ciprofloxacin, Carbamazepine, and Bisphenol on Biomass in Membrane Bioreactor System at Low Temperatures to Treat Urban Wastewater. Membranes, 13(4), 419. https://doi.org/10.3390/membranes13040419

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop